PERIPHERAL BLOOD BIOMARKERS DYNAMICS PREDICT CLINICAL RESPONSE TO PEMBROLIZUMAB PLUS CHEMOTHERAPY IN PATIENTS WITH NON-SQUAMOUS METASTATIC NON-SMALL-CELL LUNG CANCER.
| Autor: | Lora, S., Jiménez-Galán, R., Prado-Mel, E., Vega-Coca, M. D., Pérez-Moreno, M. A., Martín, L. Abdel-Kader |
|---|---|
| Zdroj: | European Journal of Hospital Pharmacy; 2024 Supplement, Vol. 31, pA180-A180, 1/2p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|